Literature DB >> 24900110

Diffuse Myocardial Uptake of (99m)Tc-HDP in Multiple Myeloma.

Koray Demirel1, Murat Sadic1, Meliha Korkmaz1, Aylin Comak1, Hasan Ikbal Atilgan1, Gökhan Koca1.   

Abstract

Soft tissue uptake is a rare finding in bone scintigraphy, with an incidence of 2%. Although the mechanism has not yet been fully clarified, several causes have been reported for this unusual uptake pattern. This paper presents a case of diffuse myocardial accumulation of technetium-99m hydroxymethylene diphosphonate ((99m)Tc-HDP) without either solid/visceral organ or soft tissue with multiple myeloma (MM) in skeletal scintigraphy. A 93-year-old man with hypertension and chronic heart failure for 14 years underwent bone scanning due to a 2-month history of back pain within a 1-year period of MM. Three hours later, (99m)Tc-HDP late static images showed diffuse myocardial radiotracer accumulation and there were no other sites of abnormal soft tissue or visceral uptake. Myocardial accumulation had disappeared on 24-h delayed static images. This accumulation was thought to be related with AL-type amyloidosis associated with MM.

Entities:  

Keywords:  Multiple myeloma; Myocardial uptake; Technetium-99m bone agents; Technetium-99m hydroxymethylene diphosphonate (99mTc-HDP)

Year:  2013        PMID: 24900110      PMCID: PMC4035187          DOI: 10.1007/s13139-013-0209-5

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  20 in total

1.  Soft tissue uptake on 99mTc methylene diphosphonate bone scan imaging: pictorial review.

Authors:  J Kaye; Mike Hayward
Journal:  Australas Radiol       Date:  2002-03

2.  Gamut: soft tissue uptake of bone radiopharmaceuticals.

Authors:  Murat Tuncel; Belkis Erbas; Babak Mahmoudian
Journal:  Semin Nucl Med       Date:  2003-10       Impact factor: 4.446

3.  Uptake of technetium 99m HDP in cardiac amyloidosis.

Authors:  Jan Kulhanek; Assad Movahed
Journal:  Int J Cardiovasc Imaging       Date:  2003-06       Impact factor: 2.357

4.  Marked soft tissue uptake of bone tracer in a patient with amyloidosis and multiple myeloma.

Authors:  T J Posch; S P Olson
Journal:  Clin Nucl Med       Date:  1992-11       Impact factor: 7.794

Review 5.  Nonosseous accumulation of bone-seeking radiopharmaceuticals.

Authors:  A Gentili; S D Miron; E M Bellon
Journal:  Radiographics       Date:  1990-09       Impact factor: 5.333

Review 6.  Abnormal radiological features in a multiple myeloma patient: a case report and radiological review of myelomas.

Authors:  S Ghosh; P Wadhwa; A Kumar; Km Pai; S Seshadri; C Manohar
Journal:  Dentomaxillofac Radiol       Date:  2011-12       Impact factor: 2.419

7.  Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis.

Authors:  S Janssen; D A Piers; M H van Rijswijk; S Meijer; E Mandema
Journal:  Eur J Nucl Med       Date:  1990

Review 8.  Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management.

Authors:  Walid Hassan; Hani Al-Sergani; Walid Mourad; Rashed Tabbaa
Journal:  Tex Heart Inst J       Date:  2005

9.  Altered radiopharmaceutical distribution in myeloma: bone tracer in the heart and heart tracer in the bone.

Authors:  A K Gupta; P Meyer; M D Gross; L M Fig; B Shapiro
Journal:  Clin Nucl Med       Date:  1998-12       Impact factor: 7.794

10.  The prognostic implications of acute myocardial infarct scintigraphy with 99mTc-pyrophosphate.

Authors:  B L Holman; R J Chisholm; E Braunwald
Journal:  Circulation       Date:  1978-02       Impact factor: 29.690

View more
  1 in total

1.  Tc-99m Hydroxymethylene Diphosphonate (HMDP) Renal Uptake as a Surrogate Marker of Postoperative Impairment of the Glomerular Filtration Rate in Renal Tumor Patients Following Nephron-Sparing Surgery.

Authors:  Hongyoon Choi; Won Woo Lee; Young So; Seunggyun Ha; Seok-Soo Byun; Sang Eun Kim
Journal:  Nucl Med Mol Imaging       Date:  2014-06-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.